http://europepmc.org/abstract/MED/24181339
McDannold N
Radiology, Brigham and Women's Hospital, 75 Francis St., Boston, MAnjm@bwh.harvard.edu.
Highlight Terms
|
The physiology of the vasculature in the central nervous system (CNS), which includes the blood-brain barrier (BBB) and other factors, severely limits the delivery of most drugs to the brain and to brain tumors. Focused ultrasound (FUS), when combined with circulating microbubbles, is a noninvasive method to locally and transiently disrupt the BBB at discrete targets and enhance delivery across the "blood-tumor barrier." This talk aims to provide insight on the current status of this unique drug delivery technique, experience with it in preclinical models, and its potential for clinical translation. In particular, methods to monitor the procedure using acoustic receivers and the feasibility of controlling and predicting drug deposition will be reviewed. If this method, which offers a flexible means to target therapeutics to desired points or volumes in the brain, can be translated to the use in humans, it can enable the use of the whole arsenal of drugs in the CNS that are currently prevented by the BBB |
No comments:
Post a Comment